• Mon. Jun 5th, 2023

Mankind Pharma will finalize the award by May 3, 2023.

Mankind Pharma will finalize the award by May 3, 2023.

Mankind Pharma IPO: Investors in the Mankind Pharma IPO can check the status of their stock allotment.

IPO of Mankind Pharma: The initial sale of Mankind Pharma shares received 15.32x subscription on the last day of the offering on Thursday, helped by huge interest from institutional buyers.

Mankind Pharma is engaged in the development, manufacture and marketing of a diverse range of pharmaceutical formulations in various acute and chronic therapeutic areas, as well as several consumer healthcare products.

The IPO received bids for 42,95,12,902 shares against 2,80,41,192 shares on offer, according to NSE data.

The Qualified Institutional Buyers (QIB) share was subscribed 49.16x, while the Non-Institutional Investor category received 3.80x subscription and Retail Individual Investors (RII) 92%.

Mankind Pharma will finalize the allocation by May 3, 2023. If not allocated, reimbursements will start on May 4. Once allocated, the shares will be credited to your demat on May 5.

The shares will be listed on the NSE and the BSE on May 8, 2023.

Refunds will be credited to the bank accounts of investors not retained by May 4 and the shares will be transferred to demat accounts by May 5.

The company’s IPO was entirely an offer for sale (OFS) of 4,00,58,844 shares by promoters and other existing shareholders.

The offer price range was 1,026 to 1,080 rupees per share.

Since the IPO is entirely an SFO, the company will not receive any net proceeds from the issuance and all net proceeds will go to selling shareholders.

The company’s shares will be listed on both the BSE and the NSE.

Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India were the offering managers.

Humanity IPO GMP

On April 29, Mankind shares were trading at a gray market premium of Rs 88, above the upper band of Rs 1,080 per share. Thus, the gray market shares were trading at Rs 1,168 each. It says the company’s shares are expected to list at a premium to its issue price on May 8, 2023. The premium fluctuates with market sentiments.

Investors in the Mankind Pharma IPO can check the status of their share allotment either on the BSE website or on the IPO Registrar’s portal by following a few simple steps;

  • Go to the official website of the ESB or the Bombay Stock Exchange. The link is (https://www.bseindia.com/investors/appli_check.aspx)
  • This will take you to a page titled “Problem Request Status”
  • After landing on the page, click on the “Equity” option
  • From the drop-down menu that will appear next to the issue name, select the “Mankind Pharma” option
  • Enter your application number on the page
  • After that write your permanent account number or PAN
  • Click on the Captcha that says “I’m not a robot” and click submit
  • After clicking on the option, the award status details of your offer. The status will only be visible after the finalization of the allocation of shares.

(With PTI inputs)

Read all the latest business news, tax news and stock market updates here

Leave a Reply

Your email address will not be published. Required fields are marked *